ABT

Pedialyte Finds New Market Niche: Binge Drinking College Students

The trend has taken off as news has spread across social media outlets (and college newspapers) by students touting its effectiveness in lessening the impacts of heavy drinking the next morning. More 

5 Reasons I Own So Many Individual Dividend Paying Stocks

In the past month, I published the list of dividend holdings I own to my subscribers. Many subscribers were amazed at the number of companies I own; here's why More 

The Good, the Bad, and the Ugly of Earnings Season

Earnings season is upon us and you can bet that it is going to spur some big swings in the market. To prepare let's preview some of the biggest names. More 

Google Bets on Healthcare — You Should, Too

Google is aiming at helping humans live longer via a new venture, Calico -- another nod at just how lucrative the healthcare space should continue to be. More 

Look Beyond Typical Dividend Growth Screens for Investments

In my early days as a dividend investor, I focused exclusively on the list of 50 or so dividend aristocrats, but investors should look beyond that screen More 

Is the Baby Bust Finished?

America's decline in fertility appears to be leveling off, and a new boom could be just a couple years away. If so, what should investors be targeting? More 

China Orders Abbott Formula Recall Over Botulism Risk

Abbott Laboratories has been asked to recall two infant formulas from the Chinese market after a New Zealand farm reported botulism contamination. More